ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: Schedule-dependent enhancement of antitumor activity

Kaye J. Williams, Brian A. Telfer, Sandra Brave, Jane Kendrew, Lynsey Whittaker, Ian J. Stratford, Stephen R. Wedge

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'ZD6474, a potent inhibitor of vascular endothelial growth factor signaling, combined with radiotherapy: Schedule-dependent enhancement of antitumor activity'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science